{"entity":{"type":"insider","cik":"0001482714","url":"/insider/0001482714","json_url":"/insider/0001482714.json","name":"MPM BIOVENTURES V GP LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2012-02-03","last":"2017-10-11","span_basis":"filed_date"},"name_variants":[{"name":"MPM BIOVENTURES V GP LLC","source":"filing","n_filings":5,"first_seen":"2012-02-03","last_seen":"2017-10-11"}],"transactions":[{"id":5282553,"accession":"0001209191-17-056612","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-056612","line_url":"/filing/0001209191-17-056612#line-2","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"MPM BIOVENTURES V LLC; MPM BIOVENTURES V GP LLC; EVNIN LUKE; GADICKE ANSBERT; MPM BIOVENTURES V, L.P.; MPM ASSET MANAGEMENT INVESTORS BV5 LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":1700000.0,"total_display":"1,700,000.00","shares_owned_after":2696392.0,"shares_owned_after_display":"2,696,392","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-10","filed_date":"2017-10-11","scope":"insider"},{"id":6442190,"accession":"0001209191-14-020007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-020007","line_url":"/filing/0001209191-14-020007#line-1","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"KAILIAN VAUGHN M; MPM BIOVENTURES V LLC; MPM BIOVENTURES V, L.P.; MPM ASSET MANAGEMENT INVESTORS BV5 LLC; GADICKE ANSBERT; MPM BIOVENTURES V GP LLC; Foley Todd; Scopa James Paul; EVNIN LUKE","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600000.0,"shares_display":"600,000","price_per_share":20.02,"price_display":"20.02","price_state":"stated","total_value":12012000.0,"total_display":"12,012,000.00","shares_owned_after":2751048.0,"shares_owned_after_display":"2,751,048","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-10","filed_date":"2014-03-12","scope":"insider"},{"id":4645107,"accession":"0001209191-13-038625","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-038625","line_url":"/filing/0001209191-13-038625#line-3","is_derivative":false,"issuer_cik":"0001358309","issuer_name":"Conatus Pharmaceuticals Inc","issuer_ticker":"CNAT","issuer_name_source":null,"issuer_url":"/issuer/0001358309","owner_cik":null,"owner_name":"MPM BioVentures IV QP LP; MPM BioVentures IV GP LLC; MPM BioVentures IV LLC; MPM BioVentures IV GmbH & Co. Beteiligungs KG; MPM Asset Management Investors BV4 LLC; MPM BIOVENTURES V LLC; MPM BIOVENTURES V, L.P.; MPM ASSET MANAGEMENT INVESTORS BV5 LLC; MPM BIOVENTURES V GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":165265.0,"shares_display":"165,265","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":1817915.0,"total_display":"1,817,915.00","shares_owned_after":1192080.0,"shares_owned_after_display":"1,192,080","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-30","filed_date":"2013-08-01","scope":"insider"},{"id":4846486,"accession":"0001209191-13-034981","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-13-034981","line_url":"/filing/0001209191-13-034981#line-4","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"Foley Todd; GADICKE ANSBERT; KAILIAN VAUGHN M; MPM BIOVENTURES V GP LLC; MPM BIOVENTURES V LLC; MPM BIOVENTURES V, L.P.; MPM ASSET MANAGEMENT INVESTORS BV5 LLC; Scopa James Paul; EVNIN LUKE","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","shares_owned_after":4351050.0,"shares_owned_after_display":"4,351,050","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-02","filed_date":"2013-07-02","scope":"insider"},{"id":2743349,"accession":"0001209191-12-007620","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-007620","line_url":"/filing/0001209191-12-007620#line-1","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"Verastem, Inc.","issuer_ticker":"VSTM","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"EVNIN LUKE; Scopa James Paul; MPM BIOVENTURES V, L.P.; MPM ASSET MANAGEMENT INVESTORS BV5 LLC; St Peter Steven; MPM BIOVENTURES V LLC; Vander Vort John; KAILIAN VAUGHN M; MPM BIOVENTURES V GP LLC; Foley Todd","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stoc","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":1000000.0,"total_display":"1,000,000.00","shares_owned_after":2033333.0,"shares_owned_after_display":"2,033,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-01","filed_date":"2012-02-03","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001649904","name":"RHYTHM PHARMACEUTICALS, INC.","url":"/issuer/0001649904","role":"Ten percent owner","n_filings":1,"first_seen":"2017-10-11","last_seen":"2017-10-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001509190","name":"ARATANA THERAPEUTICS, INC.","url":"/issuer/0001509190","role":"Ten percent owner","n_filings":2,"first_seen":"2013-07-02","last_seen":"2014-03-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001383701","name":"Conatus Pharmaceuticals Inc","url":"/issuer/0001383701","role":"Ten percent owner","n_filings":1,"first_seen":"2013-08-01","last_seen":"2013-08-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001526119","name":"Verastem, Inc.","url":"/issuer/0001526119","role":"Other","n_filings":1,"first_seen":"2012-02-03","last_seen":"2012-02-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001482714","retrieved_at":"2026-08-21T20:06:48+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}